Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'olsalazine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kilic, D; Ozenirler, S; Egehan, I; Dursun, A
      Sulfasalazine decreases acute gastrointestinal complications due to pelvicradiotherapy

      ANNALS OF PHARMACOTHERAPY
    2. Margetts, PJ; Churchill, DN; Alexopoulou, I
      Interstitial nephritis in patients with inflammatory bowel disease treatedwith mesalamine

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    3. Kruis, W; Schreiber, S; Theuer, D; Brandes, JW; Schutz, E; Howaldt, S; Krakamp, B; Hamling, J; Monnikes, H; Koop, I; Stolte, M; Pallant, D; Ewald, U
      Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three timesdaily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses

      GUT
    4. Mahmud, N; Kamm, MA; Dupas, JL; Jewell, DP; O'Morain, CA; Weir, DG; Kelleher, D
      Olsalazine is not superior to placebo in maintaining remission of inactiveCrohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study

      GUT
    5. Hussain, FN; Ajjan, RA; Riley, SA
      Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    6. Ang, YS; Mahmud, N; White, B; Byrne, M; Kelly, A; Lawler, M; McDonald, GSA; Smith, OP; Keeling, PWN
      Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    7. Corrigan, G; Stevens, PE
      Interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    8. Sonta, T; Araki, Y; Kubokawa, M; Tamura, Y; Ochiai, T; Harada, N; Chijiiwa, Y; Nawata, H
      The beneficial effect of mesalazine on esophageal ulcers in intestinal Behcet's disease

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    9. Kilic, D; Egehan, I; Ozenirler, S; Dursun, A
      Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy

      RADIOTHERAPY AND ONCOLOGY
    10. Brown, WA; Farmer, KC; Skinner, SA; Malcontenti-Wilson, C; Misajon, A; O'Brien, PE
      5-aminosalicylic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer

      DIGESTIVE DISEASES AND SCIENCES
    11. Fleig, WE
      Clinical effects of 5-aminosalicyclic acid preparations in Crohn's disease

      MEDIZINISCHE KLINIK
    12. Ardizzone, S; Petrillo, M; Imbesi, V; Cerutti, R; Bollani, S; Porro, GB
      Is maintenance therapy always necessary for patients with ulcerative colitis in remission?

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    13. Rembacken, BJ; Snelling, AM; Hawkey, PM; Chalmers, DM; Axon, ATR
      Escherichia coli for ulcerative colitis - Reply

      LANCET
    14. Rembacken, BJ; Snelling, AM; Hawkey, PM; Chalmers, DM; Axon, ATR
      Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

      LANCET
    15. Kruis, W; Pohl, C
      How to prevent a flare-up in ulcerative colitis

      DRUGS OF TODAY
    16. Mahmud, N; Weir, DG; Kelleher, D
      Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease

      IRISH JOURNAL OF MEDICAL SCIENCE
    17. SENTONGO TAS; PICCOLI DA
      RECURRENT PERICARDITIS DUE TO MESALAMINE HYPERSENSITIVITY - A PEDIATRIC CASE-REPORT AND REVIEW OF THE LITERATURE

      Journal of pediatric gastroenterology and nutrition
    18. RILEY SA
      WHAT DOSE OF 5-AMINOSALICYLIC ACID (MESALAZINE) IN ULCERATIVE-COLITIS

      Gut
    19. SUTHERLAND LR; ROTH DE; BECK PL
      ALTERNATIVES TO SULFASALAZINE - A METAANALYSIS OF 5-ASA IN THE TREATMENT OF ULCERATIVE-COLITIS

      Inflammatory bowel diseases
    20. ERIKSSON A; NYHOLM L
      ELECTROCHEMICAL DETECTION OF DISODIUM 3,3'-AZOBIS-(6-HYDROXY-)BENZOATE (OLSALAZINE SODIUM)

      Electroanalysis
    21. MODIGLIANI R
      DRUG-THERAPY FOR ULCERATIVE-COLITIS DURING PREGNANCY

      European journal of gastroenterology & hepatology
    22. BENNO P; ALAM M; MIDTVEDT T; URIBE A
      SULFASALAZINE, OLSALAZINE AND SULFAPYRIDINE INDUCE MITOGENIC ACTIONS IN THE RAT INTESTINAL EPITHELIUM

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    23. MARTEAU P; CELLIER C
      SIDE-EFFECTS OF 5-AMINOSALICYLIC ACID

      Gastroenterologie clinique et biologique
    24. GUNNARSSON I; PETTERSSON E; LINDBLAD S; RINGERTZ B
      OLSALAZINE-INDUCED LUPUS SYNDROME

      Scandinavian journal of rheumatology
    25. KRUIS W; SCHUTZ E; FRIC P; FIXA B; JUDMAIER G; STOLTE M
      DOUBLE-BLIND COMPARISON OF AN ORAL ESCHERICHIA-COLI PREPARATION AND MESALAZINE IN MAINTAINING REMISSION OF ULCERATIVE-COLITIS

      Alimentary pharmacology & therapeutics
    26. KARAMANOLIS DG; PAPATHEODORIDIS GV; XOURGIAS V
      SYSTEMIC ABSORPTION OF 5-AMINOSALICYLIC ACID IN PATIENTS WITH INACTIVE ULCERATIVE-COLITIS TREATED WITH OLSALAZINE AND MESALAZINE

      European journal of gastroenterology & hepatology
    27. MARTENSON JA; HYLAND G; MOERTEL CG; MAILLIARD JA; OFALLON JR; COLLINS RT; MORTON RF; TEWFIK HH; MOORE RL; FRANK AR; URIAS RE; DEMING RL
      OLSALAZINE IS CONTRAINDICATED DURING PELVIC RADIATION-THERAPY - RESULTS OF A DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL

      International journal of radiation oncology, biology, physics
    28. GIONCHETTI P; CAMPIERI M; VENTURI A; RIZZELLO F; FERRETTI M; BRIGNOLA C; MIGLIOLI M
      SYSTEMIC AVAILABILITY OF 5-AMINOSALICYLIC ACID - COMPARISON OF DELAYED RELEASE AND AN AZO-BOND PREPARATION

      Alimentary pharmacology & therapeutics
    29. EWE K; BECKER K; UEBERSCHAER B
      SYSTEMIC UPTAKE OF 5-AMINOSALICYLIC ACID FROM OLSALAZINE AND EUDRAGIT-L COATED MESALAZINE IN PATIENTS WITH ULCERATIVE-COLITIS IN REMISSION

      Zeitschrift fur Gastroenterologie
    30. KRUIS W; JUDMAIER G; KAYASSEH L; STOLTE M; THEUER D; SCHEURLEN C; HENTSCHEL E; KRATOCHVIL P
      DOUBLE-BLIND DOSE-FINDING STUDY OF OLSALAZINE VERSUS SULFASALAZINE ASMAINTENANCE THERAPY FOR ULCERATIVE-COLITIS

      European journal of gastroenterology & hepatology
    31. CHAWLA A; KARL PI; REICH RN; NARASIMHAN G; MICHAUD GA; FISHER SE; SCHNEIDER BL
      EFFECT OF OLSALAZINE ON SODIUM-DEPENDENT BILE-ACID TRANSPORT IN RAT ILEUM

      Digestive diseases and sciences
    32. SNINSKY CA
      NEW SALICYLATES AS MAINTENANCE TREATMENT IN ULCERATIVE-COLITIS

      Gut
    33. BRAY VJ; WEST SG; SCHULTZ KT; BOUMPAS DT; RUBIN RL
      ANTIHISTONE ANTIBODY PROFILE IN SULFASALAZINE INDUCED LUPUS

      Journal of rheumatology
    34. TRAVIS SPL; JEWELL DP
      SALICYLATES FOR ULCERATIVE-COLITIS - THEIR MODE OF ACTION

      Pharmacology & therapeutics
    35. CLERICI C; GENTILI G; BOSCHETTI E; SANTUCCI C; ABURBEH AG; NATALINI B; PELLICCIARI R; MORELLI A
      AMINO-ACID DERIVATIVES OF 5-ASA AS NOVEL PRODRUGS FOR INTESTINAL DRUG-DELIVERY

      Digestive diseases and sciences
    36. ALLGAYER H; RANG S; KLOTZ U; BOHNE P; RETEY J; KRUIS W; GUGLER R
      SUPEROXIDE INHIBITION FOLLOWING DIFFERENT STIMULI OF RESPIRATORY BURST AND METABOLISM OF AMINOSALICYLATES IN NEUTROPHILS

      Digestive diseases and sciences
    37. FALLINGBORG J; CHRISTENSEN LA; JACOBSEN BA; INGEMANNIELSEN M; RASMUSSEN HH; ABILDGAARD K; RASMUSSEN SN
      EFFECT OF OLSALAZINE AND MESALAZINE ON INTRALUMINAL PH OF THE DUODENUM AND PROXIMAL JEJUNUM IN HEALTHY HUMANS

      Scandinavian journal of gastroenterology
    38. JARNEROT G
      NEW SALICYLATES AS MAINTENANCE TREATMENT IN ULCERATIVE-COLITIS

      Gut
    39. SARROUJ BJ; ZAMPINO DJ; CILURSU AM
      PERICARDITIS AS THE INITIAL MANIFESTATION OF INFLAMMATORY BOWEL-DISEASE

      Chest
    40. YOUNG CA; SONNENBERG A; BURNS EA
      LYMPHOCYTE-PROLIFERATION RESPONSE TO BAKERS-YEAST IN CROHNS-DISEASE

      Digestion
    41. FINNIE IA; GILMORE IT
      SKIN RASH, FEVER AND RIGORS CAUSED BY OLSALAZINE

      European journal of gastroenterology & hepatology
    42. HARDY JG; HARVEY WJ; SPARROW RA; MARSHALL GB; STEED KP; MACARIOS M; WILDING IR
      LOCALIZATION OF DRUG-RELEASE SITES FROM AN ORAL SUSTAINED-RELEASE FORMULATION OF 5-ASA (PENTASA(R)) IN THE GASTROINTESTINAL-TRACT USING GAMMA-SCINTIGRAPHY

      Journal of clinical pharmacology
    43. HANAUER S; SCHWARTZ J; ROBINSON M; ROUFAIL W; ARORA S; CELLO J; SAFOI M; CARLISLE WR; OUTIM L; COCHRAN JL; INGLE S; BRISTOW WJ; CELLO JP; GRENDELL J; SATOW J; SCHWARTZ JL; JURCIK I; WHITE L; SALES D; GOCHNOUR S; HANAUER SB; HANAN I; LASHNER BA; SCHULTZ P; SIMMONS M; JAMES D; ROSENBERG F; KIRCH EP; ALLEN HA; WEBER B; RICK G; HARTONG W; BUSER W; BRYANT P; ARORA S; MCKUSICK A; WEINBERG D; PRIES J; TOMBERS J; GILBERSTADT S; HANNA P; WATSON MJ; MATTISON M; DUBOW RA; BARREIRO MA; GITCHELL L; KATZ S; KATZ S; ESKREIS D; KAHN C; WITTMANN J; GRIFFIN PH; HOLT P; HOSAT S; ATTIA A; KIMBALL AJ; BARENBERG D; LAX JD; GABRIEL JB; SESSIONS JT; BOZYYMSKI E; JONES RS; JOHNSON J; GARRETT JW; RUPEN A; PHILLIPS L; MERTESDORF J; HIESTAND F; TUCKER P; ROBERTS T; BRUNDAGE P; GRIFFIN T; BECK JE; ROUFAIL W; BRICE R; FINA M; MURPHY D; ALLMAN D; SAFDI M; SAFDI A; SCHNEIDER R; WAISSBLUTH G; MAGAW L; OBRIEN K; ROBINSON M; MELLOW M; MCFADDEN R; NEUMANN D; DORROUGH C; HELIN K; COINTEPAS CJP; MEEK RR; LORBER S; KOLENDA B; ENGLISHZYCH S; FRANK D; WRUBLE L; LEWIS M; LEVINSON M; DRAGUTSKY M; DAVIDSON O; SAMUELS A; BARNES A; BLACK L; BRIGGS RL; LAWLIS V; FELGER C; KITZMILLER G; LIEBERMANN T; FRACHTMAN R; FISCHER C; LANZA FL; DAVIS R; TRABANINO JG; RACK MF; GUERNSEY B; BESHEARS L; HOOP R; GREGORY S; MALONE N
      MESALAMINE CAPSULES FOR TREATMENT OF ACTIVE ULCERATIVE-COLITIS - RESULTS OF A CONTROLLED TRIAL

      The American journal of gastroenterology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 13:25:49